POTPOURRI OF CARDIOLOGY: FROM INNOVATION TO PRACTICE

Sunday, March 9, 2025

5:10 PM - 6:05 PM ET

Moderator(s)

Nabil Dib, MD, MSc, FACC

Director Cardiovascular Research
Mercy Gilbert Medical Center/Dignity Health
Gilbert, Arizona, United States

No relationships to disclose
Stanton J. Rowe, PhD

CEO
NXT Biomedical
Irvine, California, United States

No relationships to disclose
Robert S. Schwartz, MD, FACC, FSCAI

President
DeHaan Center for Medical Innovation
Longboat Key, Florida, United States

Disclosure(s): Corflow: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)

Disclosure(s):

Nabil Dib, MD, MSc, FACC, FESC: Dib UltraNav Medical, LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Stanton J. Rowe, PhD: Gradient Denervation: Director (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Nidus Biomedical: Employee (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing); Symbiosis Ltd: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Vivifi Medical: Director (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)

Robert S. Schwartz, MD, FACC, FSCAI: Corflow: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)